Cargando…
Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study
BACKGROUND: There is ongoing controversy regarding abacavir use in the treatment of HIV infection and the risk of subsequent development of cardiovascular disease. It is unclear how the risk varies as exposure accumulates. METHODS: Using an administrative health-plan dataset, risk of cardiovascular...
Autores principales: | Dorjee, Kunchok, Baxi, Sanjiv M., Reingold, Arthur L., Hubbard, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660446/ https://www.ncbi.nlm.nih.gov/pubmed/29078761 http://dx.doi.org/10.1186/s12879-017-2808-8 |
Ejemplares similares
-
Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States
por: Dorjee, Kunchok, et al.
Publicado: (2021) -
First report of multi-drug resistant tuberculosis in a systemic lupus erythematosus patient
por: Dorjee, Kunchok, et al.
Publicado: (2015) -
Abacavir antiretroviral therapy and indices of subclinical vascular disease in persons with HIV
por: Martinez, Claudia A., et al.
Publicado: (2022) -
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
por: Palacios, R, et al.
Publicado: (2010) -
Abacavir forms novel cross-linking abacavir protein adducts in patients
por: Meng, Xiaoli, et al.
Publicado: (2014)